Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:37 pm Sale |
2020-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM |
Boxer Capital LLC | 265,743 4.990% |
-247,617 (-48.23%) |
Filing History |
| 2021-02-16 4:29 pm Sale |
2020-12-31 | 13G | Mereo BioPharma Group plc MREO |
Boxer Capital LLC | 10,309,250 9.100% |
-10,052,625 (-49.37%) |
Filing History |
| 2021-02-16 4:22 pm Sale |
2020-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Boxer Capital LLC | 2,358,005 4.990% |
-405,564 (-14.68%) |
Filing History |
| 2021-01-20 4:31 pm Purchase |
2021-01-08 | 13G | Merus N.V. MRUS |
Boxer Capital LLC | 1,600,000 5.500% |
1,600,000 (New Position) |
Filing History |
| 2020-12-18 07:22 am Purchase |
2020-12-08 | 13G | ARS Pharmaceuticals, Inc. SPRY |
Boxer Capital LLC | 1,675,377 4.800% |
3 (+0.00%) |
Filing History |
| 2020-12-17 4:37 pm Purchase |
2020-12-08 | 13G | ARS Pharmaceuticals, Inc. SPRY |
Boxer Capital LLC | 1,675,374 4.800% |
1,675,374 (New Position) |
Filing History |
| 2020-10-30 9:44 pm Purchase |
2020-10-28 | 13D | Mirati Therapeutics, Inc. MRTX |
Boxer Capital LLC | 10,290,847 18.900% |
1,522,564 (+17.36%) |
Filing History |
| 2020-09-30 4:33 pm Purchase |
2020-09-25 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Boxer Capital LLC | 2,268,236 5.100% |
2,268,236 (New Position) |
Filing History |
| 2020-09-24 4:47 pm Purchase |
2020-09-14 | 13G | CymaBay Therapeutics, Inc. CBAY |
Boxer Capital LLC | 4,000,000 5.800% |
4,000,000 (New Position) |
Filing History |
| 2020-09-01 4:31 pm Purchase |
2020-08-28 | 13D | Odonate Therapeutics, Inc. ODTC |
Boxer Capital LLC | 0 12.600% |
0 (+60.03%) |
Filing History |
| 2020-08-07 5:15 pm Purchase |
2020-07-28 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital LLC | 4,345,016 13.000% |
4,345,016 (New Position) |
Filing History |
| 2020-08-03 4:31 pm Purchase |
2020-07-23 | 13G | Milestone Pharmaceuticals Inc. MIST |
Boxer Capital LLC | 1,777,194 7.200% |
1,777,194 (New Position) |
Filing History |
| 2020-07-29 9:05 pm Purchase |
2020-07-21 | 13D | PANDION THERAPEUTICS INC PAND |
Boxer Capital LLC | 2,107,513 7.400% |
2,107,513 (New Position) |
Filing History |
| 2020-07-20 4:37 pm Purchase |
2020-07-10 | 13G | Therapeutics Acquisition Corp. RACA |
Boxer Capital LLC | 1,500,000 8.800% |
1,500,000 (New Position) |
Filing History |
| 2020-06-29 6:19 pm Purchase |
2020-06-19 | 13G | IDEAYA Biosciences, Inc. IDYA |
Boxer Capital LLC | 2,202,812 7.800% |
2,202,812 (New Position) |
Filing History |
| 2020-06-05 4:31 pm Purchase |
2020-06-03 | 13G | Mereo BioPharma Group plc MREO |
Boxer Capital LLC | 20,361,875 9.500% |
8,109,160 (+66.18%) |
Filing History |
| 2020-05-11 5:16 pm Purchase |
2020-04-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Boxer Capital LLC | 2,763,569 7.600% |
2,763,569 (New Position) |
Filing History |